Skip to content

NL Industries NL Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Other financials

Income statement

See full
Revenue$40.6M+0.7%
Gross profit$13.3M+9.0%
Operating income$4.1M+30.5%
Net income$4.3M+551%
EPS (diluted)$0.09+800%

Balance sheet

See full
Cash & equivalents$101.9M-7.4%
Total debt$926.0K
Total equity$359.3M-9.6%
Total assets$461.2M-11.3%

Cash flow

See full
Operating cash flow-$3.5M+92.5%
CapEx$404.0K-50.9%
Free cash flow-$3.9M+91.8%

Valuation

See full
Market cap$290.95M+0.3%
Enterprise value$189.96M
P/S1.8×-0.1×

Profitability

See full
Gross margin31.1%+1.5pp
Operating margin7.3%-19.4pp
Net margin-21.5%-62.7pp
FCF margin21.1%

Returns & leverage

See full
Return on equity-9%-25.0pp
Debt / equity
Current ratio10.7×+4.8×